About the Company
We do not have any company description for Co-Diagnostics, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
80
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CODX News
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of ...
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
About Co-Diagnostics, Inc.: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies.
Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic
Latest financial insights from Quest Diagnostics. Q1 results beat estimates with adjusted EPS of $2.04 and sales of $2.34 ...
Quest Diagnostics: Q1 Earnings Snapshot
SECAUCUS, N.J. — SECAUCUS, N.J. — Quest Diagnostics Inc. (DGX) on Tuesday reported first-quarter earnings of $194 million. The Secaucus, New Jersey-based company said it had profit of $1.72 per share.
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
Quest Diagnostics DGX is set to release first-quarter 2024 results on Apr 23 before the opening bell. The company posted ...
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
SALT LAKE CITY, April 4, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of ...
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2023 Earnings Call Transcript March 14, 2024 Co-Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see ...
Loading the latest forecasts...